{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:16:48Z","timestamp":1791191808704,"version":"4.1.0"},"reference-count":123,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T00:00:00Z","timestamp":1260748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:p><jats:italic>Benzodiazepines (BZDs) are widely used by heroin users not in treatment, and by patients in methadone and buprenorphine (BPN) treatment. This review examines the epidemiology of BZD use by opioid users, and the range of harms that are associated with BZD use in this group, including the association of BZD use with opioid\u2010related mortality. Preclinical and clinical data regarding pharmacokinetic and pharmacodynamic interactions between methadone, buprenorphine, and BZDs are reviewed. An overview of treatment approaches for managing BZD use in this population is presented, including strategies for minimizing abuse and addressing BZD dependence.<\/jats:italic>\u2002(Am J Addict 2009;19:59\u201372)<\/jats:p>","DOI":"10.1111\/j.1521-0391.2009.00007.x","type":"journal-article","created":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T14:46:41Z","timestamp":1260802001000},"page":"59-72","source":"Crossref","is-referenced-by-count":104,"title":["Benzodiazepines, Methadone and Buprenorphine: Interactions and Clinical Management"],"prefix":"10.1111","volume":"19","author":[{"given":"Nicholas","family":"Lintzeris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,12,16]]},"reference":[{"key":"e_1_2_17_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199212000-00005"},{"key":"e_1_2_17_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00175-6"},{"key":"e_1_2_17_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90090-D"},{"key":"e_1_2_17_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(81)90061-2"},{"key":"e_1_2_17_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826088709027476"},{"key":"e_1_2_17_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1993.tb02020.x"},{"key":"e_1_2_17_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01731.x"},{"key":"e_1_2_17_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(01)00161-2"},{"key":"e_1_2_17_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.07.017"},{"key":"e_1_2_17_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(92)90005-W"},{"key":"e_1_2_17_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(95)01171-9"},{"key":"e_1_2_17_13_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0790966700002445"},{"key":"e_1_2_17_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952999108992807"},{"key":"e_1_2_17_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1987.tb01508.x"},{"key":"e_1_2_17_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.951217858.x"},{"key":"e_1_2_17_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550880802122620"},{"key":"e_1_2_17_18_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1995.tb126051.x"},{"key":"e_1_2_17_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90092-5"},{"key":"e_1_2_17_20_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2004.tb06293.x"},{"key":"e_1_2_17_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1994.tb00985.x"},{"key":"e_1_2_17_22_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.176.3.285"},{"key":"e_1_2_17_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230500286039"},{"key":"e_1_2_17_24_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700019899"},{"key":"e_1_2_17_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.08.011"},{"key":"e_1_2_17_26_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.3.1348"},{"key":"e_1_2_17_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/0959523021000023225"},{"key":"e_1_2_17_28_2","volume-title":"Report commissioned by the Ministerial Council on Drug Strategy through the Cost Shared Funding Model with the Victorian Department of Human Services","author":"Nielsen S","year":"2008"},{"key":"e_1_2_17_29_2","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.9.1.40"},{"key":"e_1_2_17_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/09687639997296"},{"key":"e_1_2_17_31_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v24n04_02"},{"key":"e_1_2_17_32_2","first-page":"104","article-title":"Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: Characteristics and a pharmacotherapeutic approach","volume":"39","author":"Bleich A","year":"2002","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"e_1_2_17_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.09.006"},{"key":"e_1_2_17_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyl207"},{"key":"e_1_2_17_35_2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5694\/j.1326-5377.1997.tb122318.x","article-title":"Methadone\u2010related overdose deaths in South Australia, 1984\u20131994. How safe is methadone prescribing","volume":"166","author":"Williamson PA","year":"1997","journal-title":"Med J Australia"},{"key":"e_1_2_17_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.951778.x"},{"key":"e_1_2_17_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0379-0738(01)00454-6"},{"key":"e_1_2_17_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(02)00304-1"},{"key":"e_1_2_17_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/22.6.430"},{"key":"e_1_2_17_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2006.03.037"},{"key":"e_1_2_17_41_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2009.tb02729.x"},{"key":"e_1_2_17_42_2","doi-asserted-by":"publisher","DOI":"10.1159\/000050711"},{"key":"e_1_2_17_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02939579"},{"key":"e_1_2_17_44_2","first-page":"64","article-title":"Alprazolam and benzodiazepine dependence","volume":"54","author":"Sellers EM","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_17_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(91)90044-Y"},{"key":"e_1_2_17_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050793"},{"key":"e_1_2_17_47_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0022-3565(25)22081-X","article-title":"In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution","volume":"227","author":"Arendt RM","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_17_48_2","unstructured":"StaffordJ DegenhardtL BlackeE et al.Australian Drug Trends 2005: Findings from the Illicit Drug Reporting System (IDRS). In:NDARC Monograph No. 59. Sydney Australia ;2006: p.139."},{"key":"e_1_2_17_49_2","first-page":"237","article-title":"Relative abuse liability of different benzodiazepines in drug abusers","volume":"40","author":"Griffiths RR","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_17_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.fbp.0000172736.11994.3c"},{"key":"e_1_2_17_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199608000-00001"},{"key":"e_1_2_17_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0856-7"},{"key":"e_1_2_17_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/chir.10303"},{"key":"e_1_2_17_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1993.tb05666.x"},{"key":"e_1_2_17_55_2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0090-9556(24)12022-3","article-title":"The effect of diazepam on the metabolism of methadone by the liver of methadone dependent rats","volume":"2","author":"Spaulding TC","year":"1974","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_17_56_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0022-5347(24)06140-8","article-title":"Effect of diazepam, desmethylimipramine, and SKF 525\u2010A on the disposition of levo\u2010methadone in mice after single or double injection","volume":"7","author":"Shah NS","year":"1979","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_17_57_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-3565(25)31113-4","article-title":"Correlation of urinary excretion of methadone metabolites with methadone metabolism and analgesia in the rat","volume":"204","author":"Liu S","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_17_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(96)03549-4"},{"key":"e_1_2_17_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.22"},{"key":"e_1_2_17_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(86)90051-7"},{"key":"e_1_2_17_61_2","first-page":"818","article-title":"Human buprenorphine N\u2010dealkylation is catalyzed by cytochrome P450 3A4","volume":"26","author":"Kobayashi K","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_17_62_2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3565(24)36604-2","article-title":"Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine","volume":"281","author":"Ohtani M","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_17_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2005.08.002"},{"key":"e_1_2_17_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00436-7"},{"key":"e_1_2_17_65_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.6.768"},{"key":"e_1_2_17_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2005.02.002"},{"key":"e_1_2_17_67_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.7.1164"},{"key":"e_1_2_17_68_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfn163"},{"key":"e_1_2_17_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/65.1.107"},{"key":"e_1_2_17_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.01.004"},{"key":"e_1_2_17_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2008.00273.x"},{"key":"e_1_2_17_72_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000219050.33008.61"},{"key":"e_1_2_17_73_2","unstructured":"NielsenS LintzerisN LeeN BondA et al.Examining the interaction between alprazolam and buprenorphine\/naloxone in opioid substitution treatment patients.Paper presented at: The College on Problems of Drug Dependence Annual Meeting. Quebec Canada ;2008."},{"key":"e_1_2_17_74_2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-3565(25)21486-0","article-title":"Effects of diazepam on arterial blood gas concentrations and pH of adult rats acutely and chronically exposed to methadone","volume":"230","author":"McCormick GY","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_17_75_2","doi-asserted-by":"publisher","DOI":"10.1191\/0960327102ht303oa"},{"key":"e_1_2_17_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.215"},{"key":"e_1_2_17_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.05.019"},{"key":"e_1_2_17_78_2","unstructured":"NielsenS LintzerisN LeeN et al.Pharmacodynamic interactions of alprazolam in methadone and buprenorphinenaloxone patients.Paper presented at: The College on Problems of Drug Dependence (CPDD) 70th Annual Meeting. San Juan PR ;2008."},{"key":"e_1_2_17_79_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.9556874.x"},{"key":"e_1_2_17_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.12.008"},{"key":"e_1_2_17_81_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200418010-00004"},{"key":"e_1_2_17_82_2","first-page":"17","volume-title":"Benzodiazepines","author":"Curran HV","year":"2000"},{"key":"e_1_2_17_83_2","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-4-6"},{"key":"e_1_2_17_84_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.179.5.390"},{"key":"e_1_2_17_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(81)90348-8"},{"key":"e_1_2_17_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426529"},{"key":"e_1_2_17_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200108000-00024"},{"key":"e_1_2_17_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(88)90086-0"},{"key":"e_1_2_17_89_2","doi-asserted-by":"publisher","DOI":"10.2165\/00139709-200625020-00002"},{"key":"e_1_2_17_90_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200008210-00004"},{"key":"e_1_2_17_91_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197505222922106"},{"key":"e_1_2_17_92_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199706000-00016"},{"key":"e_1_2_17_93_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.3.1339"},{"key":"e_1_2_17_94_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199610000-00005"},{"key":"e_1_2_17_95_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199011000-00005"},{"key":"e_1_2_17_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050606"},{"key":"e_1_2_17_97_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v25n03_03"},{"key":"e_1_2_17_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.08.011"},{"key":"e_1_2_17_99_2","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick RP","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_17_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/62.10.1172"},{"key":"e_1_2_17_101_2","first-page":"1","volume-title":"SAMHSA DASIS Report: Older adults in substance abuse treatment","year":"2005"},{"key":"e_1_2_17_102_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/clinchem\/40.3.373","article-title":"Detecting benzodiazepines: Immunoassays compared with negative chemical ionization gas chromatography\/mass spectrometry","volume":"40","author":"Fitzgerald RL","year":"1994","journal-title":"Clin Chem"},{"key":"e_1_2_17_103_2","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Charney DS","year":"2006"},{"key":"e_1_2_17_104_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701303360506"},{"key":"e_1_2_17_105_2","first-page":"225","article-title":"Meta\u2010analysis of benzodiazepine use in the treatment of insomnia","volume":"162","author":"Holbrook AM","year":"2000","journal-title":"CMAJ"},{"key":"e_1_2_17_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsmc.2008.01.007"},{"key":"e_1_2_17_107_2","doi-asserted-by":"publisher","DOI":"10.1002\/msj.20041"},{"key":"e_1_2_17_108_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200923020-00002"},{"key":"e_1_2_17_109_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.clinpsy.2.022305.095219"},{"key":"e_1_2_17_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00144-6"},{"key":"e_1_2_17_111_2","doi-asserted-by":"publisher","DOI":"10.1901\/jaba.1982.15-493"},{"key":"e_1_2_17_112_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005194.pub2"},{"key":"e_1_2_17_113_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810290060012"},{"key":"e_1_2_17_114_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02364.x"},{"key":"e_1_2_17_115_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2006.01565.x"},{"key":"e_1_2_17_116_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.178.4.317"},{"key":"e_1_2_17_117_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050798"},{"key":"e_1_2_17_118_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.189.3.213"},{"key":"e_1_2_17_119_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1614.2003.01211.x"},{"key":"e_1_2_17_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(93)90078-G"},{"key":"e_1_2_17_121_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230500125138"},{"key":"e_1_2_17_122_2","doi-asserted-by":"publisher","DOI":"10.1080\/713659419"},{"key":"e_1_2_17_123_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02007.x"},{"key":"e_1_2_17_124_2","article-title":"NSW Drug and Alcohol Withdrawal Clinical Practice Guidelines","author":"NSW Department of Health","year":"2008","journal-title":"NSW Department of Health"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1521-0391.2009.00007.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1521-0391.2009.00007.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T20:19:26Z","timestamp":1739477966000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1521-0391.2009.00007.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,16]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1521-0391.2009.00007.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1521-0391.2009.00007.x","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"value":"1055-0496","type":"print"},{"value":"1521-0391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,16]]}}}